US 11,918,812 B2
Vagus nerve and carotid baroreceptor stimulation system
Imad Libbus, Houston, TX (US); Bruce H. Kenknight, Houston, TX (US); and Badri Amurthur, Houston, TX (US)
Assigned to LivaNova USA, Inc., Houston, TX (US)
Filed by LivaNova USA, Inc., Houston, TX (US)
Filed on Apr. 21, 2020, as Appl. No. 16/854,054.
Application 15/680,139 is a division of application No. 14/457,754, filed on Aug. 12, 2014, granted, now 9,737,716.
Application 16/854,054 is a continuation of application No. 15/680,139, filed on Aug. 17, 2017, granted, now 10,646,716.
Prior Publication US 2020/0246623 A1, Aug. 6, 2020
Int. Cl. A61N 1/36 (2006.01); A61N 1/05 (2006.01)
CPC A61N 1/36146 (2013.01) [A61N 1/36057 (2013.01); A61N 1/36114 (2013.01); A61N 1/36139 (2013.01); A61N 1/0551 (2013.01); A61N 1/0556 (2013.01); A61N 1/36053 (2013.01); A61N 1/36117 (2013.01)] 19 Claims
OG exemplary drawing
 
1. A method of operating an implantable neurostimulation system, comprising:
delivering a carotid baroreceptor stimulation (CBS) therapy to carotid baroreceptors of a patient for a treatment of chronic heart failure, according to a set of parameters, with a pulse generator via a CBS electrode assembly having at least one CBS electrode contact and an integrated pressure sensor configured to sense a blood pressure of the patient, the at least one CBS electrode contact and the integrated pressure sensor integrated into a single cuff structure;
determining an activity level of the patient based on the sensed blood pressure of the patient; and
modifying the set of parameters of the CBS therapy based on the determined activity level, wherein, in a first activity level state, the CBS therapy is delivered at a first intensity and, in a second activity level state, the CBS therapy is delivered at a second intensity different than the first intensity.